AptarGroup, Inc.

ATR Healthcare Medical Instruments & Supplies

AptarGroup, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.8 billion, up 5.42% from fiscal 2024.

Revenue
+6.03%
EPS
−73.9%
Free cash flow
−16.9%
Total debt
+14.6%

Quarter to September 2026, against a year earlier

143.84 3.02 −2.06%
Market cap
$9.1B
P/E
34.6×
Fwd P/E
25.9×
Dividend yield
1.00%
F-score
5/9
Altman Z
3.78
Beneish M
−2.48
Dividend safety
92/100

AptarGroup, Inc. (ATR) Free cash flow

Alert me on Free cash flow

AptarGroup, Inc.'s free cash flow for fiscal 2025 was $298.1M, down 15.0% from $350.7M in fiscal 2024. Over the twelve months to 30 September 2026 it was $295.0M. Over the past ten years it has ranged from $60.7M (fiscal 2021) to $350.7M (fiscal 2024); the current reading is higher than 82% of that period. AptarGroup, Inc. ranks 11th of 51 Medical Instruments & Supplies companies by free cash flow.

Free cash flow, annual

Embed this chart

Annual newest first

Period Free cash flow Change
FY2025 $298.1M (15.00%)
FY2024 $350.7M 33.77%
FY2023 $262.2M 60.76%
FY2022 $163.1M 168.52%
FY2021 $60.7M (81.22%)
FY2020 $323.4M 19.03%
FY2019 $271.7M 155.74%
FY2018 $106.2M (37.56%)
FY2017 $170.1M (12.98%)
FY2016 $195.5M 11.55%

Quarterly newest first

Period Free cash flow Change
Sep 2026 $96.5M 105.54%
Jun 2026 $46.9M (13.15%)
Mar 2026 $54.0M (44.64%)
Dec 2025 $97.6M (15.88%)
43 more quarters

Against its own ten years

Low $60.7M High $350.7M
Ten-year median $195.5M
Current reading's percentile 82

Free cash flow against peers

What Free cash flow is

Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.

Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)

The full definition of Free cash flow →

More on ATR